Figure 5From: Immunohistochemical detection of Polo-like kinase-1 (PLK1) in primary breast cancer is associated with TP53mutation and poor clinical outcomeKaplan-Meier survival analysis of patients with Grade 3 tumours. (A) Data correlating PLK1 staining to breast cancer-specific survival. P = 0.004. (B) Stratification of the data to show the influence of p53 status on the association between PLK1 staining and breast cancer-specific survival. P = 0.006. The number of patients at 1-, 5- and 10-year time points are shown below each panel.Back to article page